A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India

Indumathi Manoharan, Rathnam Boopathy, Sultan Darvesh, Oksana Lockridge

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

Background: Butyrylcholinesterase (BChE; gi:116353) deficiency has adverse effects on the response to succinylcholine and mivacurium. A physiological function of BChE is to inactivate octanoyl ghrelin. We determined the health effect of complete absence of BChE in humans. Methods: Clinical tests of cardiac, lung, liver, and kidney function, body weight, sperm counts and motility were performed on 5 men, age 20-32 y, in the Vysya community of Coimbatore, India who had silent BChE. Postmortem tissues from 2 cadavers with wild-type BChE were assayed. Results: Test results were normal, except for lung function, which indicated mild obstruction in silent as well as in wild-type BChE subjects. Creatine kinase-MB levels were high in 2 subjects, but there were no other indications of damage to the heart. Body weight was normal. Family histories revealed no trend in disease susceptibility. The human body contains 10 times more BChE than acetylcholinesterase molecules. Conclusion: Individuals completely deficient in BChE have only minor abnormalities in clinical test results. However, they respond abnormally to standard doses of succinylcholine and mivacurium. It is expected, but not proven, that they are unusually susceptible to the toxicity of cocaine and organophosphorus pesticides, and resistant to bambuterol and irinotecan. Their normal body weight suggests alternative routes for deactivation of octanoyl ghrelin.

Original languageEnglish (US)
Pages (from-to)128-135
Number of pages8
JournalClinica Chimica Acta
Volume378
Issue number1-2
DOIs
StatePublished - Mar 1 2007

Fingerprint

Butyrylcholinesterase
Ideal Body Weight
irinotecan
Succinylcholine
Ghrelin
India
Health
MB Form Creatine Kinase
Lung
Sperm Count
Sperm Motility
Disease Susceptibility
Acetylcholinesterase
Cocaine
Human Body
Cadaver
Pesticides
Body Weight
Kidney
Liver

Keywords

  • Butyrylcholinesterase deficiency
  • Ghrelin
  • Mivacurium
  • Succinylcholine

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India. / Manoharan, Indumathi; Boopathy, Rathnam; Darvesh, Sultan; Lockridge, Oksana.

In: Clinica Chimica Acta, Vol. 378, No. 1-2, 01.03.2007, p. 128-135.

Research output: Contribution to journalArticle

Manoharan, Indumathi ; Boopathy, Rathnam ; Darvesh, Sultan ; Lockridge, Oksana. / A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India. In: Clinica Chimica Acta. 2007 ; Vol. 378, No. 1-2. pp. 128-135.
@article{40467762dd764680baf260ad108e5682,
title = "A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India",
abstract = "Background: Butyrylcholinesterase (BChE; gi:116353) deficiency has adverse effects on the response to succinylcholine and mivacurium. A physiological function of BChE is to inactivate octanoyl ghrelin. We determined the health effect of complete absence of BChE in humans. Methods: Clinical tests of cardiac, lung, liver, and kidney function, body weight, sperm counts and motility were performed on 5 men, age 20-32 y, in the Vysya community of Coimbatore, India who had silent BChE. Postmortem tissues from 2 cadavers with wild-type BChE were assayed. Results: Test results were normal, except for lung function, which indicated mild obstruction in silent as well as in wild-type BChE subjects. Creatine kinase-MB levels were high in 2 subjects, but there were no other indications of damage to the heart. Body weight was normal. Family histories revealed no trend in disease susceptibility. The human body contains 10 times more BChE than acetylcholinesterase molecules. Conclusion: Individuals completely deficient in BChE have only minor abnormalities in clinical test results. However, they respond abnormally to standard doses of succinylcholine and mivacurium. It is expected, but not proven, that they are unusually susceptible to the toxicity of cocaine and organophosphorus pesticides, and resistant to bambuterol and irinotecan. Their normal body weight suggests alternative routes for deactivation of octanoyl ghrelin.",
keywords = "Butyrylcholinesterase deficiency, Ghrelin, Mivacurium, Succinylcholine",
author = "Indumathi Manoharan and Rathnam Boopathy and Sultan Darvesh and Oksana Lockridge",
year = "2007",
month = "3",
day = "1",
doi = "10.1016/j.cca.2006.11.005",
language = "English (US)",
volume = "378",
pages = "128--135",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - A medical health report on individuals with silent butyrylcholinesterase in the Vysya community of India

AU - Manoharan, Indumathi

AU - Boopathy, Rathnam

AU - Darvesh, Sultan

AU - Lockridge, Oksana

PY - 2007/3/1

Y1 - 2007/3/1

N2 - Background: Butyrylcholinesterase (BChE; gi:116353) deficiency has adverse effects on the response to succinylcholine and mivacurium. A physiological function of BChE is to inactivate octanoyl ghrelin. We determined the health effect of complete absence of BChE in humans. Methods: Clinical tests of cardiac, lung, liver, and kidney function, body weight, sperm counts and motility were performed on 5 men, age 20-32 y, in the Vysya community of Coimbatore, India who had silent BChE. Postmortem tissues from 2 cadavers with wild-type BChE were assayed. Results: Test results were normal, except for lung function, which indicated mild obstruction in silent as well as in wild-type BChE subjects. Creatine kinase-MB levels were high in 2 subjects, but there were no other indications of damage to the heart. Body weight was normal. Family histories revealed no trend in disease susceptibility. The human body contains 10 times more BChE than acetylcholinesterase molecules. Conclusion: Individuals completely deficient in BChE have only minor abnormalities in clinical test results. However, they respond abnormally to standard doses of succinylcholine and mivacurium. It is expected, but not proven, that they are unusually susceptible to the toxicity of cocaine and organophosphorus pesticides, and resistant to bambuterol and irinotecan. Their normal body weight suggests alternative routes for deactivation of octanoyl ghrelin.

AB - Background: Butyrylcholinesterase (BChE; gi:116353) deficiency has adverse effects on the response to succinylcholine and mivacurium. A physiological function of BChE is to inactivate octanoyl ghrelin. We determined the health effect of complete absence of BChE in humans. Methods: Clinical tests of cardiac, lung, liver, and kidney function, body weight, sperm counts and motility were performed on 5 men, age 20-32 y, in the Vysya community of Coimbatore, India who had silent BChE. Postmortem tissues from 2 cadavers with wild-type BChE were assayed. Results: Test results were normal, except for lung function, which indicated mild obstruction in silent as well as in wild-type BChE subjects. Creatine kinase-MB levels were high in 2 subjects, but there were no other indications of damage to the heart. Body weight was normal. Family histories revealed no trend in disease susceptibility. The human body contains 10 times more BChE than acetylcholinesterase molecules. Conclusion: Individuals completely deficient in BChE have only minor abnormalities in clinical test results. However, they respond abnormally to standard doses of succinylcholine and mivacurium. It is expected, but not proven, that they are unusually susceptible to the toxicity of cocaine and organophosphorus pesticides, and resistant to bambuterol and irinotecan. Their normal body weight suggests alternative routes for deactivation of octanoyl ghrelin.

KW - Butyrylcholinesterase deficiency

KW - Ghrelin

KW - Mivacurium

KW - Succinylcholine

UR - http://www.scopus.com/inward/record.url?scp=33846969163&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846969163&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2006.11.005

DO - 10.1016/j.cca.2006.11.005

M3 - Article

C2 - 17182021

AN - SCOPUS:33846969163

VL - 378

SP - 128

EP - 135

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

IS - 1-2

ER -